Evidence map›Paper›PMID 35794839›Full record

ArticleAmerican journal of hematology2022

Thrombocytopenia, anasarca, and severe inflammation.

Amanallah Montazeripouragha, Christine M Campbell, James Russell, Nadia Medvedev, Daniel R Owen, Alison Harris, Fergal Donnellan, Iain McCormick, David C Fajgenbaum, Luke Y C Chen

Abstract read
In one paragraph

Article in American journal of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amanallah MontazeripouraghaInternal Medicine Residency Program, Department of Medicine, University of British Columbia, Vancouver, Canada.ORCID 0000-0002-6294-7588
Christine M CampbellInternal Medicine Residency Program, Department of Medicine, University of British Columbia, Vancouver, Canada.
James RussellDepartment of Radiology, University of British Columbia, Vancouver, Canada.
Nadia MedvedevDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Daniel R OwenDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.ORCID 0000-0002-1386-9624
Alison HarrisDepartment of Radiology, University of British Columbia, Vancouver, Canada.
Fergal DonnellanDivision of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, Canada.
Iain McCormickDivision of General Internal Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada.
David C FajgenbaumDivision of Translational Medicine and Human Genetics, and Center for Cytokine Storm Treatment and Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA.ORCID 0000-0002-7367-8184
Luke Y C ChenDivision of Hematology, Department of Medicine, University of British Columbia, Vancouver, Canada.ORCID 0000-0002-9551-2951

Funding

mTOR as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic TargetR01HL141408 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Taku Kambayashi · 2018 to 2026
$6.1M
NHLBI NIH HHS R01 HL141408
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Castleman DiseaseLeukopeniaThrombocytopeniaEdemaHumansInflammation

Identifiers

PMID35794839
PMCPMC9555220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.